TY - JOUR AU - Wahyuni, Sri Eka AU - Daulay, Wardiyah AU - Nasution, Mahnum Lailan PY - 2022/04/07 Y2 - 2024/03/29 TI - Hallucination Management Model for Schizophrenic Patients JF - Open Access Macedonian Journal of Medical Sciences JA - Open Access Maced J Med Sci VL - 10 IS - T7 SE - Psychiatry DO - 10.3889/oamjms.2022.9453 UR - https://oamjms.eu/index.php/mjms/article/view/9453 SP - 104-107 AB - <p><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}">&nbsp;</span></p><p><strong><span data-contrast="auto">INTRODUCTION</span></strong><span data-contrast="auto">: </span><span data-contrast="auto">Hallucinations are a phenomenon that is mostly found in schizophrenic patients.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}">&nbsp;</span></p><p><strong><span data-contrast="auto">AIM</span></strong><span data-contrast="auto">: The study aim to identify the effect of the hallucination management model on the severity and distress of schizophrenic patients.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}">&nbsp;</span></p><p><strong><span data-contrast="auto">METHOD:</span></strong><span data-contrast="auto"> The study used Quasi-experimental method with</span> <span data-contrast="auto">98 respondents. Sampling was done by consecutive sampling. </span><span data-contrast="auto">Data was collected between June and July 201</span><span data-contrast="auto">6</span><span data-contrast="auto">. All of the subjects completed a questionnaire </span><span data-contrast="auto">Psychotic Syndrome Rating Scale (PSYRAT)</span><span data-contrast="auto">. The questionnaire had been tested validity and realibility with&nbsp; range of r count between 0.442-0.720 and Cronbach’s Alpha =0.891.&nbsp;&nbsp;</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}">&nbsp;</span></p><p><strong><span data-contrast="auto">RESULT</span></strong><span data-contrast="auto">: </span><span data-contrast="auto">The result of study showed that </span><span data-contrast="auto">hallucination management model reduced severity of symptoms and distress (p-value 0.001, p&lt;0.05). Hallucinations and distress of patients in the intervention group decreased significantly (p-value 0.00, p&lt;0.05).&nbsp;</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}">&nbsp;</span></p><p><strong><span data-contrast="auto">CONCLUSIONS: </span></strong><span data-contrast="auto">hallucination management model </span><span data-contrast="auto">is very important to</span><span data-contrast="auto"> patients. It is </span><span data-contrast="auto">necessary to</span><span data-contrast="auto"> hallucination management model implemented for schizophrenia</span><span data-contrast="auto">.&nbsp;</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559737&quot;:414,&quot;335559738&quot;:2,&quot;335559739&quot;:160,&quot;335559740&quot;:259}">&nbsp;</span></p> ER -